U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685600) titled 'Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants' on June 29.
Brief Summary: The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: AZD4144
AZD4144 will be administered orally.
DRUG: AZD4144
AZD4144 will be administered as an IV infusion.
DRUG: Itraconazole
Itraconazole will be administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curate...